1. Acknowledgement

   Announcement 24 August 2012 Pages: 677 - 679

2. Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug

   • Sandeep Dutta
   • Ronald C. Reed

   Original Research Article 24 August 2012 Pages: 681 - 690

   

3. Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast Cancer

   • David Sarid
   • Ilan G. Ron
   • Neora Yaal-Hahoshen

   Original Research Article 24 August 2012 Pages: 691 - 701

   

4. Comparison of Diurnal Intraocular Pressure Control by Latanoprost versus Travoprost

   • Philippe Denis
   • Robert Launois
   • Gilles Berdeaux

   Original Research Article 24 August 2012 Pages: 703 - 714

   

5. Evaluation of Chromogranin A Expression in Patients with Non-Neuroendocrine Tumours

   • F. Tropea
   • S. Baldari
   • A. Herberg

   Original Research Article 24 August 2012 Pages: 715 - 722

   

6. Role of Androgen Ablation with Low-Dose-Rate Brachytherapy in the Treatment of Prostate Cancer

   • Ashesh B. Jani
   • Asal Shoushtari
   • Jeffrey M. Feinstein

   Original Research Article 24 August 2012 Pages: 723 - 731

   

7. Real-Life Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin or Macrolides

   • T. Schaberg
   • M. Möller
   • H. Landen

   Original Research Article 24 August 2012 Pages: 733 - 744

   

8. Metoclopramide-Induced Delayed Non-Thrombocytopenic Purpuric Rash

   • S. Upputuri
   • S. Prasad

   Case Report 24 August 2012 Pages: 745 - 747